BCM
TBIO

Bridgeway Capital Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Bridgeway Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,722
Closed -$29.5K – 1356
2024
Q1 		$29.5K Hold
3,722
– – ﹤0.01% 1285
2023
Q4 		$26.7K Sell
3,722
-2,778
-43% -$30.9K ﹤0.01% 1336
2023
Q3 		$122K Hold
6,500
– – ﹤0.01% 1191
2023
Q2 		$185K Hold
6,500
– – ﹤0.01% 1151
2023
Q1 		$363K Hold
6,500
– – 0.01% 960
2022
Q4 		$146K Hold
6,500
– – ﹤0.01% 1153
2022
Q3 		$194K Buy
+6,500
New +$229K 0.01% 1147

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DWS
Dynamic Wealth Strategies Granite Bay, California $173M AUM 14.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $152B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return